| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.2M | -7.6% |
| Cost of Revenue | $64.2M | -4.0% |
| Gross Profit | $75.0M | -10.5% |
| R&D Expense | $24.6M | +5.4% |
| SG&A Expense | $38.4M | -22.0% |
| Operating Income | -$820K | +97.5% |
| Pre-tax Income | -$2.4M | +93.8% |
| Income Tax | $7.7M | +157.1% |
| Net Income | -$10.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.8M | +2.7% |
| Accounts Receivable | $12.7M | -8.2% |
| Current Assets | $136.9M | -0.3% |
| Total Assets | $173.7M | -1.8% |
| Current Liabilities | $38.0M | -44.0% |
| Total Liabilities | $45.4M | -40.2% |
| Stockholders' Equity | $128.2M | +27.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.9M | +1431.6% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$7.6M | -4.6% |
| Financing Cash Flow | -$22.1M | +51.3% |
| Free Cash Flow | $23.9M | — |
| +75.7% |
| EPS (Basic) | -$0.12 | +76.0% |
| EPS (Diluted) | -$0.12 | +76.0% |